Cell death controlling complexes and their potential therapeutic role

Cellular and Molecular Life Sciences

Volumn 72, Issue 3, 2015, Pages 505-517

  Zamaraev, Alexey V ^a   Kopeina, Gelina S ^a   Zhivotovsky, Boris ^a,b   Lavrik, Inna N ^a,c  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Apoptosome; Caspases; Cell death; DISC; PIDDosome; Protein complexes; RIPoptosome

Indexed keywords

APOPTOSOME; CASPASE 2; CASPASE 8; DEATH RECEPTOR; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; MULTIPROTEIN COMPLEX;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELLULAR PARAMETERS; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME MODIFICATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; NECROPTOSIS; NECROSOME; NONHUMAN; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RIPOPTOSOME; SIGNAL TRANSDUCTION; STOICHIOMETRY; BIOLOGICAL MODEL; METABOLISM; NECROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

APOPTOSOMES; CASPASE 2; CELL DEATH; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; NECROSIS; SIGNAL TRANSDUCTION;

EID: 84921342043     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1757-2     Document Type: Article

References (122)

1. Vaux DL, Korsmeyer SJ (1999) Cell death in development. Cell 96:245-254
2. Kroemer G, Galluzzi L, Vandenabeele P et al (2009) Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ 16:3-11
3. Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532-542
4. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700-714
5. Galluzzi L, Kepp O, Krautwald S, Kroemer G, Linkermann A (2014) Molecular mechanisms of regulated necrosis. Semin Cell Dev Biol 35:24-32
6. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660
7. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641-652
8. Kuranaga E (2012) Beyond apoptosis: caspase regulatory mechanisms and functions in vivo. Genes Cells 17:83-97
9. Ciraci C, Janczy JR, Sutterwala FS, Cassel SL (2012) Control of innate and adaptive immunity by the inflammasome. Microbes Infect 14:1263-1270
10. Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22:8543-8567
11. Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137-161
12. Mittl PR, Di Marco S, Krebs JF et al (1997) Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J Biol Chem 272:6539-6547
13. Wei Y, Fox T, Chambers SP et al (2000) The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol 7:423-432
14. Riedl SJ, Renatus M, Schwarzenbacher R et al (2001) Structural basis for the inhibition of caspase-3 by XIAP. Cell 104:791-800
15. Chai J, Shiozaki E, Srinivasula SM et al (2001) Structural basis of caspase-7 inhibition by XIAP. Cell 104:769-780
16. Weber CH, Vincenz C (2001) The death domain superfamily: a tale of two interfaces? Trends Biochem Sci 26:475-481
17. Dickens LS, Powley IR, Hughes MA, MacFarlane M (2012) The, "complexities" of life and death: death receptor signalling platforms. Exp Cell Res 318:1269-1277
18. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273:2926-2930
19. Stennicke HR, Salvesen GS (2000) Caspases: controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta Protein Struct Mol Enzymol 1477:299-306
20. Muzio M, Chinnaiyan AM, Kischkel FC et al (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827
21. Lavrik IN, Krammer PH (2012) Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 19:36-41
22. Sessler T, Healy S, Samali A, Szegezdi E (2013) Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Pharmacol Ther 140:186-199
23. Schleich K, Warnken U, Fricker N et al (2012) Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell 47:306-319
24. Dickens LS, Boyd RS, Jukes-Jones R et al (2012) A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 47:291-305
25. Martin DA, Siegel RM, Zheng L, Lenardo MJ (1998) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem 273:4345-4349
26. Chang DW, Xing Z, Capacio VL, Peter ME, Yang X (2003) Interdimer processing mechanism of procaspase-8 activation. EMBO J 22:4132-4142
27. Hoffmann JC, Pappa A, Krammer PH, Lavrik IN (2009) A new C-terminal cleavage product of procaspase-8, p30, defines an alternative pathway of procaspase-8 activation. Mol Cell Biol 29:4431-4440
28. Kallenberger SM, Beaudouin J, Claus J et al (2014) Intra- and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis. Sci Signal 7:ra23
29. Varfolomeev E, Maecker H, Sharp D et al (2005) Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280:40599-40608
30. Lavrik IN, Mock T, Golks A, Hoffmann JC, Baumann S, Krammer PH (2008) CD95 stimulation results in the formation of a novel death effector domain protein-containing complex. J Biol Chem 283:26401-26408
31. Cullen SP, Henry CM, Kearney CJ et al (2013) Fas/CD95-induced chemokines can serve as "Find-Me" signals for apoptotic cells. Mol Cell 49:1034-1048
32. Geserick P, Hupe M, Moulin M et al (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187:1037-1054
33. Varfolomeev EE, Ashkenazi A (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116:491-497
34. Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45-65
35. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190
36. Haas TL, Emmerich CH, Gerlach B et al (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and? Is required for TNF-mediated gene induction. Mol Cell 36:831-844
37. Gerlach B, Cordier SM, Schmukle AC et al (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471:591-596
38. Ikeda F, Deribe YL, Skånland SS et al (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471:637-641
39. Harper N, Hughes M, MacFarlane M, Cohen GM (2003) Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J Biol Chem 278:25534-25541
40. Oztürk S, Schleich K, Lavrik IN (2012) Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp Cell Res 318:1324-1331
41. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN (2005) c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 280:14507-14513
42. Fricker N, Beaudouin J, Richter P, Eils R, Krammer PH, Lavrik IN (2010) Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J Cell Biol 190:377-389
43. Pop C, Oberst A, Drag M et al (2011) FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 433:447-457
44. Ofengeim D, Yuan J (2013) Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol 14:727-736
45. Christofferson DE, Li Y, Yuan J (2014) Control of life-or-death decisions by RIP1 kinase. Annu Rev Physiol 76:129-150
46. Cho Y, Challa S, Moquin D et al (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112-1123
47. Li J, McQuade T, Siemer AB et al (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150:339-350
48. Moriwaki K, Chan FK-M (2013) RIP3: a molecular switch for necrosis and inflammation. Genes Dev 27:1640-1649
49. Degterev A, Huang Z, Boyce M et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119
50. Teng X, Degterev A, Jagtap P et al (2005) Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 15:5039-5044
51. Degterev A, Hitomi J, Germscheid M et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313-321
52. Choi S, Keys H, Staples RJ, Yuan J, Degterev A, Cuny GD (2012) Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability. Bioorganic Med Chem Lett 22:5685-5688
53. Sun L, Wang H, Wang Z et al (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213-227
54. Murphy JM, Czabotar PE, Hildebrand JM et al (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39:443-453
55. Dondelinger Y, Declercq W, Montessuit S et al (2014) MLKL compromises plasma membrane integrity upon binding to phosphatidyl inositol phosphates. Cell Rep 7:1-11
56. Chen X, Li W, Ren J et al (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24:105-121
57. Wang H, Sun L, Su L et al (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54:133-146
58. Moujalled DM, Cook WD, Okamoto T et al (2013) TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis 4:e465
59. Feoktistova M, Geserick P, Kellert B et al (2011) CIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43:449-463
60. Tenev T, Bianchi K, Darding M et al (2011) The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43:432-448
61. Feoktistova M, Geserick P, Panayotova-Dimitrova D, Leverkus M (2012) Pick your poison: the ripoptosome, a cell death platform regulating apoptosis and necroptosis. Cell Cycle 11:460-467
62. Vanlangenakker N, Bertrand MJM, Bogaert P, Vandenabeele P, Vanden Berghe T (2011) TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2:e230
63. Remijsen Q, Goossens V, Grootjans S et al (2014) Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis 5:e1004
64. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219
65. Kagan VE, Tyurin VA, Jiang J et al (2005) Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1:223-232
66. Yuan S, Akey CW (2013) Apoptosome structure, assembly, and procaspase activation. Structure 21:501-515
67. Twiddy D, Brown DG, Adrain C et al (2004) Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem 279:19665-19682
68. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23:2134-2145
69. Yuan S, Topf M, Reubold TF, Eschenburg S, Akey CW (2013) Changes in apaf-1 conformation that drive apoptosome assembly. Biochemistry 52:2319-2327
70. Malladi S, Challa-Malladi M, Fearnhead HO, Bratton SB (2009) The Apaf-1 procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer. EMBO J 28:1916-1925
71. Li P, Nijhawan D, Budihardjo I et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
72. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y (1999) Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549-557
73. Yuan S, Yu X, Topf M, Ludtke SJ, Wang X, Akey CW (2010) Structure of an apoptosome-procaspase-9 CARD complex. Structure 18:571-583
74. Würstle ML, Laussmann MA, Rehm M (2012) The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp Cell Res 318:1213-1220
75. Yuan S, Yu X, Asara JM, Heuser JE, Ludtke SJ, Akey CW (2011) The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3. Structure 19:1084-1096
76. Reubold TF, Eschenburg S (2012) A molecular view on signal transduction by the apoptosome. Cell Signal 24:1420-1425
77. Hu Q, Wu D, Chen W, Yan Z, Shi Y (2013) Proteolytic processing of the caspase-9 zymogen is required for apoptosome-mediated activation of caspase-9. J Biol Chem 288:15142-15147
78. Tinel A, Tschopp J (2004) The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304:843-846
79. Bouchier-Hayes L, Oberst A, McStay GP et al (2009) Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell 35:830-840
80. Jang TH, Zheng C, Wu H, Jeon JH, Park HH (2010) In vitro reconstitution of the interactions in the PIDDosome. Apoptosis 15:1444-1452
81. Janssens S, Tinel A (2012) The PIDDosome, DNA-damage-induced apoptosis and beyond. Cell Death Differ 19:13-20
82. Park HH, Logette E, Raunser S et al (2007) Death domain assembly mechanism revealed by crystal structure of the? Oligomeric PIDDosome core complex. Cell 128:533-546
83. Janssens S, Tinel A, Lippens S, Tschopp J (2005) PIDD mediates NF-kappaB activation in response to DNA damage. Cell 123:1079-1092
84. Tinel A, Janssens S, Lippens S et al (2007) Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J 26:197-208
85. Ando K, Kernan JL, Liu PH et al (2012) PIDD death-domain phosphorylation by ATM controls Prodeath versus prosurvival PIDDosome signaling. Mol Cell 47:681-693
86. Manzl C, Krumschnabel G, Bock F et al (2009) Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol 185:291-303
87. Kim IR, Murakami K, Chen NJ et al (2009) DNA damage- and stress-induced apoptosis occurs independently of PIDD. Apoptosis 14:1039-1049
88. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B (2006) Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 25:5683-5692
89. Imre G, Heering J, Takeda A-N et al (2012) Caspase-2 is an initiator caspase responsible for pore-forming toxin-mediated apoptosis. EMBO J 31:2615-2628
90. Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4:139-163
91. Siegel RM, Frederiksen JK, Zacharias DA et al (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288:2354-2357
92. Siegel RM, Chan FK, Chun HJ, Lenardo MJ (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469-474
93. O'Reilly LA, Tai L, Lee L et al (2009) Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 461:659-663
94. Lavrik IN (2014) Systems biology of death receptor networks: live and let die. Cell Death Dis 5:e1259
95. Scaffidi C, Fulda S, Srinivasan A et al (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675-1687
96. Yin XM, Wang K, Gross A et al (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400:886-891
97. Vercammen D, Beyaert R, Denecker G et al (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187:1477-1485
98. Holler N, Zaru R, Micheau O et al (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1:489-495
99. Chan FK-M, Shisler J, Bixby JG et al (2003) A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278:51613-51621
100. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326
101. Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49-63
102. Gupta S, Kass GEN, Szegezdi E, Joseph B (2009) The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 13:1004-1033
103. Kulikov AV, Shilov ES, Mufazalov IA, Gogvadze V, Nedospasov SA, Zhivotovsky B (2012) Cytochrome c: the Achilles' heel in apoptosis. Cell Mol Life Sci 69:1787-1797
104. Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71
105. Kerr JFR, Wyllie AH (1972) CAR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
106. Akbari-Birgani S, Hosseinkhani S, Mollamohamadi S, Baharvand H (2014) Delay in apoptosome formation attenuates apoptosis in mouse. Embryonic stem cell differentiation. J Biol Chem 289:16905-16913
107. D'Brot A, Chen P, Vaishnav M, Yuan S, Akey CW, Abrams JM (2013) Tango7 directs cellular remodeling by the Drosophila apoptosome. Genes Dev 27:1650-1655
108. Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V (2012) Role of apoptosis in disease. Aging (Albany NY) 4:330-349
109. Yu X, Deng Q, Bode AM, Dong Z, Cao Y (2013) The role of necroptosis, an alternative form of cell death, in cancer therapy. Expert Rev Anticancer Ther 13:883-893
110. Bouralexis S, Findlay DM, Evdokiou A (2005) Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis 10:35-51
111. Humphreys RC, Halpern W (2008) Trail receptors: targets for cancer therapy. Adv Exp Med Biol 615:127-158
112. Stegehuis JH, de Wilt LH, de Vries EGE, Groen HJ, de Jong S, Kruyt FE (2010) TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives. Drug Resist Update 13:2-15
113. Samali A, Szegezdi E, Mahalingham D et al (2009) Trail variants for treating cancer. WO2009077857-A2
114. Rosen GD (2000) Combined therapy of diterpenoid triepoxides and trail for synergistic killing of tumor cells. WO2000048619-A1
115. Zhao Y, Butler EB, Tan M (2013) Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 4:e532
116. Kurokawa M, Kim J, Geradts J et al (2013) A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53. Sci Signal 6:ra32
117. Queudeville M, Seyfried F, Eckhoff SM et al (2012) Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling. Cell Death Dis 3:e364
118. Hector S, Conlon S, Schmid J et al (2012) Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer. Br J Cancer 106:1499-1505
119. Chen W, Wang Q, Bai L et al (2014) RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis. Cell Death Differ 21:1061-1070
120. Johansson B, Mertens F, Mitelman F (1993) Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosom Cancer 8:205-218
121. Nam JY, Jong WL, Yun JK et al (2004) Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS 112:330-335
122. Holleman A, Den Boer ML, Kazemier KM et al (2005) Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 106:1817-1823